Defendant Name:
SCWorx Corp.
Defendant Type:
Public Company
SIC Code:
9999
CUSIP:
78396V10
Document Reference:
comp-pr2022-94
Document Details
Legal Case Name
SEC v. Marc S. Schessel and SCWorx Corp.
Document Name
Complaint
Document Date
31-May-2022
Document Format
Civil Proceeding
Case Number
22-cv-03287
Federal District Court
New Jersey, District of New Jersey
Allegation Type
Securities Offering
Document Summary
The Commission stated: "[i]n April 2020, during the outbreak of the coronavirus disease 2019 (COVID-19) pandemic, NASDAQ-listed securities issuer SCWorx Corp. (ticker: WORX) and its Chief Executive Officer, Schessel, issued false and misleading press releases and other statements claiming that SCWorx would supply millions of COVID-19 test kits to an online healthcare company based in Fairfield, New Jersey ("Telehealth Company"), in exchange for hundreds of millions of dollars. In reality, not only was there no agreement for SCWorx to provide COVID-19 test kits to Telehealth Company, SCWorx did not even have a legitimate supplier for the COVID-19 test kits."
Other Defendants in Action: